Bene has the golden goose, not Paradigm. It's that simple. Paradigm are spending all the $$$ to prove that Bene's product works in humans (and also to pay for PR's and DS lifestyles).
PR is trying to get greedy with the deals, but really he's not in a very strong negotiating position.
If Paradigm owned and manufactured the product, PAR would be worth billions now, but alas, they are just over $100mill.
Even the German fund didn't buy any more shares in the recent capital raising and it's debatable whether they still have their previous stated holdings.
Where we at?, page-9
-
- There are more pages in this discussion • 698 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $96.19M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 27.5¢ | $50.60K | 182.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1818 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 27600 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |